The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes

被引:156
作者
Rachez, C
Gamble, M
Chang, CPB
Atkins, GB
Lazar, MA
Freedman, LP
机构
[1] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA
[2] Cornell Univ, Weil Med Coll, Sloan Kettering Div, New York, NY 10021 USA
[3] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/MCB.20.8.2718-2726.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcriptional activation requires both access to DNA assembled as chromatin and functional contact with components of the basal transcription machinery. Using the hormone-bound vitamin D-3 receptor (VDR) ligand binding domain (LBD) as an affinity matrix, we previously identified a novel multisubunit coactivator complex, DRIP (VDR-interacting proteins), required for transcriptional activation by nuclear receptors and several other transcription factors. In this report, we characterize the nuclear receptor binding features of DRIP205, a key subunit of the DRIP complex, that interacts directly with VDR and thyroid hormone receptor in response to ligand and anchors the other DRIP subunits to the nuclear receptor LHD. In common with other nuclear receptor coactivators, DRIP205 interaction occurs through one of two LXXLL motifs and requires the receptor's AF-2 subdomain. Although the second motif of DRIP205 is required only for VDR binding in vitro, both motifs are used in the context of an retinoid X receptor-VDR heterodimer on DNA and in transactivation in vivo. We demonstrate that both endogenous p160 coactivators and DRIP complexes bind to the VDR LBD from nuclear extracts through similar sequence requirements, but they do so as distinct complexes. Moreover, in contrast to the p160 family of coactivators, the DRIP complex is devoid of any histone acetyltransferase activity. The results demonstrate that different coactivator complexes with distinct functions bind to the same transactivation region of nuclear receptors, suggesting that they are both required for transcription activation by nuclear receptors.
引用
收藏
页码:2718 / 2726
页数:9
相关论文
共 47 条
  • [1] Transcription of chromatin: these are complex times
    Armstrong, JA
    Emerson, BM
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (02) : 165 - 172
  • [2] Coactivators for the orphan nuclear receptor RORα
    Atkins, GB
    Hu, X
    Guenther, MG
    Rachez, C
    Freedman, LP
    Lazar, MA
    [J]. MOLECULAR ENDOCRINOLOGY, 1999, 13 (09) : 1550 - 1557
  • [3] CHARACTERIZATION OF THE LIGAND-DEPENDENT TRANSACTIVATION DOMAIN OF THYROID-HORMONE RECEPTOR
    BARETTINO, D
    RUIZ, MDMV
    STUNNENBERG, HG
    [J]. EMBO JOURNAL, 1994, 13 (13) : 3039 - 3049
  • [4] Mammalian Srb Mediator complex is targeted by adenovirus E1A protein
    Boyer, TG
    Martin, MED
    Lees, E
    Ricciardi, RP
    Berk, AJ
    [J]. NATURE, 1999, 399 (6733) : 276 - 279
  • [5] Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase
    Chen, HW
    Lin, RJ
    Xie, W
    Wilpitz, D
    Evans, RM
    [J]. CELL, 1999, 98 (05) : 675 - 686
  • [6] Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
    Chen, HW
    Lin, RJ
    Schiltz, RL
    Chakravarti, D
    Nash, A
    Nagy, L
    Privalsky, ML
    Nakatani, Y
    Evans, RM
    [J]. CELL, 1997, 90 (03) : 569 - 580
  • [7] LIGAND MODULATES THE CONVERSION OF DNA-BOUND VITAMIN D-3 RECEPTOR (VDR) HOMODIMERS INTO VDR-RETINOID-X RECEPTOR HETERODIMERS
    CHESKIS, B
    FREEDMAN, LP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) : 3329 - 3338
  • [8] IDENTIFICATION OF A CONSERVED REGION REQUIRED FOR HORMONE DEPENDENT TRANSCRIPTIONAL ACTIVATION BY STEROID-HORMONE RECEPTORS
    DANIELIAN, PS
    WHITE, R
    LEES, JA
    PARKER, MG
    [J]. EMBO JOURNAL, 1992, 11 (03) : 1025 - 1033
  • [9] Structure and specificity of nuclear receptor-coactivator interactions
    Darimont, BD
    Wagner, RL
    Apriletti, JW
    Stallcup, MR
    Kushner, PJ
    Baxter, JD
    Fletterick, RJ
    Yamamoto, KR
    [J]. GENES & DEVELOPMENT, 1998, 12 (21) : 3343 - 3356
  • [10] Identification of RB18A, a 205 kDa new p53 regulatory protein which shares antigenic and functional properties with p53
    Drané, P
    Barel, M
    Balbo, M
    Frade, R
    [J]. ONCOGENE, 1997, 15 (25) : 3013 - 3024